Helicobacter infections with rare bacteria or minimal gastritis: Expecting the unexpected

Digestive and Liver Disease

Volumn 47, Issue 7, 2015, Pages 549-555

  Glickman, Jonathan N ^a   Noffsinger, Amy ^a   Nevin, Daniel T ^a   Ray, Mukunda ^a   Lash, Richard H ^a   Genta, Robert M ^a  

^a MIRACA LIFE SCIENCES   (United States)

Author keywords

Gastritis; Immunohistochemistry; Special stains

Indexed keywords

ARTICLE; CHRONIC INFLAMMATION; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY; ADULT; AGED; BIOPSY; FEMALE; GASTRIC MUCOSA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; STOMACH;

EID: 84937629603     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.04.005     Document Type: Article

References (34)

1. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1:1311-1315.
2. Marshall B.J. Campylobacter pyloridis and gastritis. Journal of Infectious Diseases 1986, 153:650-657.
3. Parsonnet J., Samloff I.M., Nelson L.M., et al. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiology, Biomarkers and Prevention 1993, 2:461-466.
4. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.R., et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991, 338:1175-1176.
5. Genta R.M., Graham D.Y. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointestinal Endoscopy 1994, 40:342-345.
6. Kedika R.R., Souza R.F., Spechler S.J. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Digestive Diseases and Sciences 2009, 54:2312-2317.
7. Kuipers E.J., Lee A., Klinkenberg-Knol E.C., et al. Review article: the development of atrophic gastritis - Helicobacter pylori and the effects of acid suppressive therapy. Alimentary Pharmacology and Therapeutics 1995, 9:331-340.
8. Graham D.Y., Genta R., Evans D.G., et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. American Journal of Gastroenterology 1996, 91:2120-2124.
9. Kuipers E.J., Klinkenberg-Knol E.C., Meuwissen S.G. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology 2000, 118:239-242.
10. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. American Journal of Surgical Pathology 1996, 20:1161-1181.
11. Genta R.M., Lash R.H. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find. American Journal of Surgical Pathology 2010, 34:e25-e34.
12. Madan E., Kemp J., Westblom T.U., et al. Evaluation of staining methods for identifying Campylobacter pylori. American Journal of Clinical Pathology 1988, 90:450-453.
13. Hartman D.J., Owens S.R. Are routine ancillary stains required to diagnose Helicobacter infection in gastric biopsy specimens? An institutional quality assurance review. American Journal of Clinical Pathology 2012, 137:255-260.
14. Smith S.B., Snow A.N., Perry R.L., et al. Helicobacter pylori: to stain or not to stain. American Journal of Clinical Pathology 2012, 137:733-738.
15. Yantiss R.K., Lamps L.W. To stain or not to stain. .That remains the question. American Journal of Clinical Pathology 2012, 137:343-345.
16. Batts K.P., Ketover S., Kakar S., et al. Appropriate use of special stains for identifying Helicobacter pylori: recommendations from the Rodger C. Haggitt Gastrointestinal Pathology Society. American Journal of Surgical Pathology 2013, 37:e12-e22.
17. Chitkara Y. Upfront special staining for Helicobacter pylori in gastric biopsy specimens is not indicated. American Journal of Clinical Pathology 2015, 143:84-88.
18. Chey W.D., Wong B.C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. American Journal of Gastroenterology 2007, 102:1808-1825.
19. Vakil N. Prescribing proton pump inhibitors: is it time to pause and rethink. Drugs 2012, 72:437-445.
20. El-Zimaity H.M., Segura A.M., Genta R.M., et al. Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Modern Pathology 1998, 11:288-291.
21. Sepulveda A.R., Patil M. Practical approach to the pathologic diagnosis of gastritis. Archives of Pathology and Laboratory Medicine 2008, 132:1586-1593.
22. Jonkers D., Stobberingh E., de Bruine A., et al. Evaluation of immunohistochemistry for the detection of Helicobacter pylori in gastric mucosal biopsies. Journal of Infection 1997, 35:149-154.
23. Eshun J.K., Black D.D., Casteel H.B., et al. Comparison of immunohistochemistry and silver stain for the diagnosis of pediatric Helicobacter pylori infection in urease-negative gastric biopsies. Pediatric and Developmental Pathology 2001, 4:82-88.
24. Collins J.S., Hamilton P.W., Watt P.C., et al. Superficial gastritis and Campylobacter pylori in dyspeptic patients - a quantitative study using computer-linked image analysis. Journal of Pathology 1989, 158:303-310.
25. -El-Zimaity H., Serra S., Szentgyorgyi E., et al. Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection. Canadian Journal of Gastroenterology 2013, 27:e25-e30.
26. Otero L.L., Ruiz V.E., Perez Perez G.I. Helicobacter pylori: the balance between a role as colonizer and pathogen. Best Practice and Research. Clinical Gastroenterology 2014, 28:1017-1029.
27. Blaser M.J. The Jeremiah Metzger Lecture: global warming redux: the disappearing microbiota and epidemic obesity. Transactions of the American Clinical and Climatological Association 2012, 123:230-238. discussion 239-41.
28. Graham D.Y. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma. Preventive Medicine 1994, 23:712-716.
29. Graham D.Y., Shiotani A. The time to eradicate gastric cancer is now. Gut 2005, 54:735-738.
30. Rugge M., Cassaro M., Leo G., et al. Helicobacter pylori and gastric cancer: both primary and secondary preventive measures are required. Archives of Internal Medicine 1999, 159:2483-2484.
31. Giuliani A., Spada S., Corona M., et al. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis. Journal of Experimental and Clinical Cancer Research 2003, 22:371-378.
32. Calabrese C., Di Febo G., Brandi G., et al. Correlation between endoscopic features of gastric antrum, histology and Helicobacter pylori infection in adults. Italian Journal of Gastroenterology and Hepatology 1999, 31:359-365.
33. Redéen S., Petersson F., Jönsson K.A., et al. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy 2003, 35:946-950.
34. Zsikla V., Hailemariam S., Baumann M., et al. Increased rate of Helicobacter pylori infection detected by PCR in biopsies with chronic gastritis. American Journal of Surgical Pathology 2006, 30:242-248.